Medtronic Tells 10th Circ. Bone Device Suit Is Preempted

Law360, New York (February 10, 2014, 9:01 PM EST) -- The Tenth Circuit should affirm a dismissal of a failure-to-warn suit against Medtronic Inc. by a patient claiming the device maker promoted its bone fusion product for off-label uses because those claims are preempted by the Federal Food, Drug and Cosmetic Act, Medtronic told the court recently.

Oklahoma federal Judge Vicki Miles-LaGrange was correct to find that Section 360k (a) of the act — which the U.S. Supreme Court has found shields medical device makers if they have complied with federal law — preempts plaintiff Patricia...
To view the full article, register now.

Related

Sections

Case Information

Case Title

Caplinger v. Medtronic, et al


Case Number

13-6061

Court

Appellate - 10th Circuit

Nature of Suit

4367 Torts

Date Filed

March 8, 2013

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.